Download PDF
Dialyse aktuell 2007; 11(2): 54-55
DOI: 10.1055/s-2007-983933
Phosphatbindertherapie der Zukunft

© Georg Thieme Verlag Stuttgart · New York

Zusammenhang zwischen Phosphatmanagement und Mortalität„

Further Information

Publication History

Publication Date:
06 June 2007 (online)

Also available at
   Permissions and Reprints

Dass die erhöhte kardiale Mortalität von Dialysepatienten im Zusammenhang mit der Gefäßkalzifizierung steht, hat die Studie von Blacher et al. [2] schon vor Jahren gezeigt. Das Ergebnis der RIND-Studie zeigt jedoch erstmals den Zusammenhang mit der Phosphatbindertherapie”, so Prof. Jürgen Bommer, Heidelberg. Über die Bedeutung der Studiendaten für die Phosphatbindertherapie der Zukunft spricht er mit Dr. Bettina Albers für die Dialyse aktuell.

Literatur

  • 1 Asmus HG, Braun J, Krause R. et al. . Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density.  Nephrol Dial Transplant. 2005;  20 1653-1661
    Google Scholar
  • 2 Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM.. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease.  Hypertension. 2001;  38
    Google Scholar
  • 3 Block GA. et al. .Effect of coronary calcification and phosphate binder. Kidney(Online-Version: ) 2007
    Google Scholar
  • 4 Block GA, Klassen PS, Lazarus JM. et al. . Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.  J Am Soc Nephrol. 2004;  15 2208-2218
    Google Scholar
  • 5 Block GA, Spiegel DM, Ehrlich J. et al. . Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis.  Kidney Int. 2005;  68 1815-1824
    Google Scholar
  • 6 Braun J, Asmus HG, Holzer H. et al. . Long-term comparison of a calcium-free phosphate binder and calcium carbonate-phosphorus metabolism and cardiovascular calcification.  Clin Nephrol. 2004;  62 104-115
    Google Scholar
  • 7 Chertow GM, Burke SK, Raggi P.. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.  Kidney Int. 2002;  62 245-252
    Google Scholar
  • 8 Foley RN, Parfrey PS, Sarnak MJ.. Clinical epidemiology of cardiovascular disease in chronic renal disease.  Am J Kidney Dis. 1998;  32 112-119
    Google Scholar
  • 9 Goodman WG, Goldin J, Kuizon BD. et al. . Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis.  N Engl J Med. 2000;  342 1478-1483
    Google Scholar
  • 10 Groß. et al. .ASN 2005/Abstract
  • 11 Guérin AP, London GM, Marchais SJ, Metivier F.. Arterial stiffening and vascular calcification in end-stage renal disease.  Nephrol Dial Transplant. 2000;  15 1014-1021
    Google Scholar
  • 12 London GM, Guérin AP, Marchais SJ. et al. . Arterial media calcification in end-stage renal disease: Impact on all cause and cardiovascular mortality.  Nephrol Dial Transplant. 2003;  18 1731-1740
    Google Scholar
  • 13 Young EW, Akiba T, Albert JM. et al. . Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS).  Am J Kidney Dis. 2004;  44 34-38
    Google Scholar
  • 14 Young EW, Albert JM, Satayathum S. et al. . Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study.  Kidney Int. 2005;  67 1179-1187
    Google Scholar
      >